116 related articles for article (PubMed ID: 17855715)
1. Charting a strategic direction for the American Society of Preventive Oncology's Survivorship Interest Group.
Trentham-Dietz A; Buist DS; Kelly KM; Jacobson JS; Paskett E;
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1912-3. PubMed ID: 17855715
[No Abstract] [Full Text] [Related]
2. Strategies to maximize the competitiveness of cancer survivorship grant applications: a report from the American Society of Preventive Oncology's Survivorship Interest Group.
Geiger AM; Strom SS; Demark-Wahnefried W; Buist DS
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2899-900. PubMed ID: 18843036
[No Abstract] [Full Text] [Related]
3. The business of research: budgets, personnel, planning, and pitfalls--a report from the American Society of Preventive Oncology's Junior Members Interest Group.
Sprague BL; Thompson CL; Ganz PA; Kanetsky PA; Kushi LH; Nebeling L
Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1802-4. PubMed ID: 21784957
[No Abstract] [Full Text] [Related]
4. Know Your Value: Negotiation Skill Development for Junior Investigators in the Academic Environment--A Report from the American Society of Preventive Oncology's Junior Members Interest Group.
Burton-Chase AM; Swartz MC; Silvera SA; Basen-Engquist K; Fletcher FE; Shields PG
Cancer Epidemiol Biomarkers Prev; 2015 Jul; 24(7):1144-8. PubMed ID: 26139841
[No Abstract] [Full Text] [Related]
5. Careers in cancer prevention: what you may not see from inside your academic department--a report from the American Society of Preventive Oncology's Junior Members Interest Group.
Nichols HB; Sprague BL; Buist DS; Erwin DO; Leach CR; Patrick H
Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1393-5. PubMed ID: 22695736
[No Abstract] [Full Text] [Related]
6. The American Society of Clinical Oncology's Blueprint for Transforming Clinical and Translational Cancer Research.
Meropol NJ; Kris MG; Winer EP
J Clin Oncol; 2012 Mar; 30(7):690-1. PubMed ID: 22215747
[No Abstract] [Full Text] [Related]
7. Effect of the American Society of Clinical Oncology's Conflict of Interest Policy on Information Overload.
Boothby A; Wang R; Cetnar J; Prasad V
JAMA Oncol; 2016 Dec; 2(12):1653-1654. PubMed ID: 27560393
[No Abstract] [Full Text] [Related]
8. Recruiting and training leadership through professional societies: a report from the American Society of Preventive Oncology Junior Members Interest Group.
Buist DS; Kanetsky PA; Studts JL; Li L; Terry MB; Trentham-Dietz A; Chang S;
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1422-4. PubMed ID: 16835350
[No Abstract] [Full Text] [Related]
9. Cancer survivorship: unique opportunities for research.
Robison LL
Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1093. PubMed ID: 15247117
[No Abstract] [Full Text] [Related]
10. Public interest groups.
Ahmed AK
Bull N Y Acad Med; 1978 Apr; 54(4):446-8. PubMed ID: 274980
[No Abstract] [Full Text] [Related]
11. Ethics in Radiation Oncology and the American Society for Radiation Oncology's Role.
Donaldson SS
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):247-249. PubMed ID: 28871964
[No Abstract] [Full Text] [Related]
12. American Psychosocial Oncology Society (APOS) celebrates Psycho-Oncology's 30 years of success.
Archer-Nanda E; Greer JA
Psychooncology; 2022 Apr; 31(4):557. PubMed ID: 35396893
[No Abstract] [Full Text] [Related]
13. Keeping our eye on the ball: the American Society of Preventive Oncology in 2009.
Marshall JR
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2796-802. PubMed ID: 19815642
[No Abstract] [Full Text] [Related]
14. The most deadly cancers.
Watson T; Rubin R; Wu C
US News World Rep; 1996 Feb; 120(5):62, 64, 65-7. PubMed ID: 10154337
[No Abstract] [Full Text] [Related]
15. Reaffirming and Clarifying the American Society of Clinical Oncology's Policy Statement on the Critical Role of Phase I Trials in Cancer Research and Treatment.
Weber JS; Levit LA; Adamson PC; Bruinooge SS; Burris HA; Carducci MA; Dicker AP; Gönen M; Keefe SM; Postow MA; Thompson MA; Waterhouse DM; Weiner SL; Schuchter LM
J Clin Oncol; 2017 Jan; 35(2):139-140. PubMed ID: 27893329
[No Abstract] [Full Text] [Related]
16. Cancer survivorship research: opportunities and future needs for expanding the research base.
Bhatia S; Robison LL
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1551-7. PubMed ID: 18628407
[No Abstract] [Full Text] [Related]
17. Oncology's perfect storm: the next decade.
Newcomer LN
Am J Manag Care; 2005 Dec; 11(17 Suppl):S507-8. PubMed ID: 16336065
[No Abstract] [Full Text] [Related]
18. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening.
Smith RA; Cokkinides V; Brawley OW
CA Cancer J Clin; 2009; 59(1):27-41. PubMed ID: 19147867
[TBL] [Abstract][Full Text] [Related]
19. Optimizing cancer survivorship.
Feuerstein M
J Cancer Surviv; 2007 Mar; 1(1):1-4. PubMed ID: 18648938
[TBL] [Abstract][Full Text] [Related]
20. Oncology's first Phase 0 trial.
Rowan K
J Natl Cancer Inst; 2009 Jul; 101(14):978-9. PubMed ID: 19584322
[No Abstract] [Full Text] [Related]
[Next] [New Search]
